CGI is a buy, says National Bank

National Bank Financial analyst Richard Tse is staying bullish on CGI (CGI Group Stock Quote, Chart, News TSX:GIB.A) after recently hosting a lunch with the company’s management.

In an update to clients on Monday, Tse says that not only is the growth runway still available for CGI, the stock has defensive attributes, as well.

Montreal-headquartered CGI, a global IT consulting and systems integration company, has seen its share price grow steadily over the years, with 2019 being no exception. GIB.A is now up more than 30 per cent year-to-date and has experienced a nice pickup in the pace since its latest earnings report earlier this month.

There, CGI reported fourth quarter revenue of $2.96 billion, up 5.7 per cent from $2.80 billion a year earlier, and a profit of $324.1 million or $1.19 per diluted share, itself an improvement on last year’s $293.5 million or $1.03 per diluted share. Adjusted EBIT was $457.5 million or 15.5 per cent of revenue.

“I’m pleased with the growth in Q4, driven by IP and our managed IT services offering,” said George D. Schindler, President and CEO, in a press release. “The full year results reflect our ongoing ability to deliver organic growth and expanding margins.”

With his update, Tse is maintaining his “Outperform” rating and price target of $120.00, which represents an estimated total return of 11 per cent at the time of publication.

The analyst had a number of takeaways from the lunch, starting with management’s claim that operating margin expansion, a characteristic of CGI’s growth in the past, is not over yet, with the company now beginning to convert former System Integration and Consulting engagements into longer-term Managed Service and IP deals which benefit from scale.

At the same time, Tse noted that while IP has been a prominent growth driver for the company over the years along with Managed Services, the analyst notes that CGI has made overall growth gains despite the paring of legacy outsourcing revenue, which accounts for less than 14 per cent of the company’s revenue today.

Finally, while acquisitions have clearly been a focus for CGI over the years, management related that the market backdrop has softened and thus valuations are improving, meaning that a pickup in M&A activity is likely.

“Overall, what we heard from the lunch was consistent with our view on the stock where we see a runway for growth (organic and inorganic) that’s not fully priced into GIB.A. In addition, we continue to like GIB.A for its defensive attributes (recurring revenue and cash flow),” writes Tse.

“The only caveat from our lunch and consistent with the Company’s results commentary is that the Company does see a slowdown in the decision-making process given the macro backdrop. That’s no different from what we’ve heard from other large competitors. For CGI, while that may mean organic growth won’t accelerate, its pipeline will as digital transformation projects are increasingly evaluated as a way to drive cost savings,” he writes.

Tse thinks that CGI will generate fiscal 2020 revenue and EBITDA of $12.8 billion and $2.4 billion, respectively, and fiscal 2021 revenue and EBITDA of $13.2 billion and $2.5 billion, respectively.

Tagged with: gib.a
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

CHAR Technologies wins price target raise from this analyst

On Oct. 22, Paradigm Capital analyst Marvin Wolff raised his target on CHAR Technologies (CHAR Technologies Stock Quote, Chart, News,… [Read More]

47 minutes ago

Can ATS stock bounce back?

Stifel analyst Justin Keywood maintained his “Buy” rating and $44.00 target on ATS Corporation (ATS Corporation  Stock Quote, Chart, News,… [Read More]

5 hours ago

Three Canadian stocks analysts think could double

Markets have been choppy, but billionaire investor Bill Ackman sees the potential for a much stronger backdrop in 2027. Speaking… [Read More]

6 hours ago

Atlas Engineered Products: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $1.00 target on Atlas Engineered Products (Atlas Engineered Products Stock… [Read More]

6 hours ago

Atrium Therapeutics is a buy, this analyst says

Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA)… [Read More]

17 hours ago

Texas Instruments is the anti-data center stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid says Texas Instruments (Texas Instruments Stock Quote, Chart, News, Analysts, Financials NASDAQ:TXN)… [Read More]

19 hours ago